Invention Grant
- Patent Title: Pharmaceutical formulation
-
Application No.: US16498943Application Date: 2018-03-28
-
Publication No.: US11559490B2Publication Date: 2023-01-24
- Inventor: Simon Geissler , Martina Jeschke , Patrizia Boniforte , Markus Weigandt
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Grüneberg and Myers, PLLC
- Priority: EP17163830 20170330
- International Application: PCT/EP2018/057877 WO 20180328
- International Announcement: WO2018/178134 WO 20181004
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/00 ; A61K9/10 ; A61K9/14 ; A61K9/16 ; A61K9/28 ; A61K9/48 ; A61K31/5377 ; A61P35/00 ; C07D413/14
Abstract:
A pharmaceutical formulation has (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)methanol or pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20210085611A1 Pharmaceutical formulation Public/Granted day:2021-03-25
Information query
